All In MedTech

FDA Clearance Tracker · P230007-S004

TriClip G4 System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 31, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 31, 2024

Approved

Time to decision

30 days

Received May 1, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P230007-S004
Device name
TriClip G4 System
Applicant location
St. Paul, MN
Received
May 1, 2024
Decided
May 31, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P230007

Device type

Device class
Class III

Every decision under product code NPS

FDA's approval statement

As written in FDA's record.

approval of the protocol for the Continued f/u of the Premarket Cohort post-approval study (PAS)

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.